ERBB2 and cancer: The active targeting linked to functionalization explains the direct effect of irradiation on cancer cells, secondary to the internalization of the anti-HER2 gold nanoshells in their cytoplasm, as previously reported in vitro [33], and in HER2-overexpressing cancer xenografts sensitive to trastuzumab [34].